1 Cancer Vaccine Market Overview
1.1 Product Overview and Scope of Cancer Vaccine
1.2 Cancer Vaccine Segment by Type
1.2.1 Global Cancer Vaccine Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Product Preventive Cancer VaccinesTherapeutic Cancer Vaccines
1.2.3 Product Type 2
1.2.4 Product Type 3
1.2.5 Others
1.3 Cancer Vaccine Segment by Application
1.3.1 Cancer Vaccine Sales Comparison by Application: (2020-2026)
1.3.2 Cervical Cancer
1.3.3 Prostate Cancer
1.3.4 Others
1.3.5 Others
1.4 Global Cancer Vaccine Market Size Estimates and Forecasts
1.4.1 Global Cancer Vaccine Revenue 2015-2026
1.4.2 Global Cancer Vaccine Sales 2015-2026
1.4.3 Cancer Vaccine Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Cancer Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Cancer Vaccine Industry
1.5.1.1 Cancer Vaccine Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Cancer Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures/Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Cancer Vaccine Players to Combat Covid-19 Impact
1.6 Study Objectives
1.7 Years Considered
2 Global Cancer Vaccine Market Competition by Manufacturers
2.1 Global Cancer Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Cancer Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Cancer Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Cancer Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Cancer Vaccine Market Competitive Situation and Trends
2.5.1 Cancer Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Cancer Vaccine Players (Opinion Leaders)
3 Cancer Vaccine Retrospective Market Scenario by Region
3.1 Global Cancer Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Cancer Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Cancer Vaccine Market Facts & Figures by Country
3.3.1 North America Cancer Vaccine Sales by Country
3.3.2 North America Cancer Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cancer Vaccine Market Facts & Figures by Country
3.4.1 Europe Cancer Vaccine Sales by Country
3.4.2 Europe Cancer Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cancer Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Cancer Vaccine Sales by Region
3.5.2 Asia Pacific Cancer Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cancer Vaccine Market Facts & Figures by Country
3.6.1 Latin America Cancer Vaccine Sales by Country
3.6.2 Latin America Cancer Vaccine Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cancer Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Cancer Vaccine Sales by Country
3.7.2 Middle East and Africa Cancer Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Cancer Vaccine Historic Market Analysis by Type
4.1 Global Cancer Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Cancer Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Cancer Vaccine Price Market Share by Type (2015-2020)
4.4 Global Cancer Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Cancer Vaccine Historic Market Analysis by Application
5.1 Global Cancer Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Cancer Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Cancer Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Cancer Vaccine Business
6.1 PaxVax Corporation.
6.1.1 Corporation Information
6.1.2 PaxVax Corporation. Description, Business Overview
6.1.3 PaxVax Corporation. Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 PaxVax Corporation. Products Offered
6.1.5 PaxVax Corporation. Recent Development
6.2 Aduro BioTech Inc.
6.2.1 Corporation Information
6.2.2 Aduro BioTech Inc. Description, Business Overview
6.2.3 Aduro BioTech Inc. Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Aduro BioTech Inc. Products Offered
6.2.5 Aduro BioTech Inc. Recent Development
6.3 Dynavax Technologies Corporation
6.3.1 Corporation Information
6.3.2 Dynavax Technologies Corporation Description, Business Overview
6.3.3 Dynavax Technologies Corporation Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Dynavax Technologies Corporation Products Offered
6.3.5 Dynavax Technologies Corporation Recent Development
6.4 Pfizer
6.4.1 Corporation Information
6.4.2 Pfizer Description, Business Overview
6.4.3 Pfizer Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Pfizer Products Offered
6.4.5 Pfizer Recent Development
6.5 Sanpower Group
6.5.1 Corporation Information
6.5.2 Sanpower Group Description, Business Overview
6.5.3 Sanpower Group Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Sanpower Group Products Offered
6.5.5 Sanpower Group Recent Development
6.6 Merck & Co., Inc.
6.6.1 Corporation Information
6.6.2 Merck & Co., Inc. Description, Business Overview
6.6.3 Merck & Co., Inc. Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Merck & Co., Inc. Products Offered
6.6.5 Merck & Co., Inc. Recent Development
6.7 Immunomic Therapeutics, Inc.
6.7.1 Corporation Information
6.7.2 Immunomic Therapeutics, Inc. Description, Business Overview
6.7.3 Immunomic Therapeutics, Inc. Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.7.4 Immunomic Therapeutics, Inc. Products Offered
6.7.5 Immunomic Therapeutics, Inc. Recent Development
6.8 Sanofi Pasteur
6.8.1 Corporation Information
6.8.2 Sanofi Pasteur Description, Business Overview
6.8.3 Sanofi Pasteur Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Sanofi Pasteur Products Offered
6.8.5 Sanofi Pasteur Recent Development
6.9 Gritstone Oncology
6.9.1 Corporation Information
6.9.2 Gritstone Oncology Description, Business Overview
6.9.3 Gritstone Oncology Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Gritstone Oncology Products Offered
6.9.5 Gritstone Oncology Recent Development
6.10 Astrazeneca Plc.
6.10.1 Corporation Information
6.10.2 Astrazeneca Plc. Description, Business Overview
6.10.3 Astrazeneca Plc. Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Astrazeneca Plc. Products Offered
6.10.5 Astrazeneca Plc. Recent Development
6.11 Bavarian Nordic
6.11.1 Corporation Information
6.11.2 Bavarian Nordic Description, Business Overview
6.11.3 Bavarian Nordic Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Bavarian Nordic Products Offered
6.11.5 Bavarian Nordic Recent Development
6.12 Glaxosmithkline Plc
6.12.1 Corporation Information
6.12.2 Glaxosmithkline Plc Description, Business Overview
6.12.3 Glaxosmithkline Plc Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Glaxosmithkline Plc Products Offered
6.12.5 Glaxosmithkline Plc Recent Development
6.13 Astellas Pharma Inc.
6.13.1 Corporation Information
6.13.2 Astellas Pharma Inc. Description, Business Overview
6.13.3 Astellas Pharma Inc. Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Astellas Pharma Inc. Products Offered
6.13.5 Astellas Pharma Inc. Recent Development
7 Cancer Vaccine Manufacturing Cost Analysis
7.1 Cancer Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cancer Vaccine
7.4 Cancer Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cancer Vaccine Distributors List
8.3 Cancer Vaccine Customers
9 Market Dynamics
9.1 Market Overview
9.2 Market Trends
9.3 Market Inclination Insights Analysis
9.4 Drivers
9.5 Opportunities
9.6 Challenges
9.7 Future Prospects
9.8 Impact Analysis of Drivers and Challenges During the Forecast Period, (2018-2028)
10 Global Market Forecast
10.1 Global Cancer Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cancer Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Cancer Vaccine by Type (2021-2026)
10.2 Cancer Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cancer Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Cancer Vaccine by Application (2021-2026)
10.3 Cancer Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cancer Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Cancer Vaccine by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
